首页> 外国专利> MIXED CRYSTALS OF INSULIN, INSULIN DERIVATIVES, A PROCESS FOR THE PREPARATION OF THESE MIXED CRYSTALS, PHARMACEUTICAL AGENTS CONTAINING THESE MIXED CRYSTALS,, THEU USE THEREOF FOR THE TREATMENT OF DIABETES MELLITUS

MIXED CRYSTALS OF INSULIN, INSULIN DERIVATIVES, A PROCESS FOR THE PREPARATION OF THESE MIXED CRYSTALS, PHARMACEUTICAL AGENTS CONTAINING THESE MIXED CRYSTALS,, THEU USE THEREOF FOR THE TREATMENT OF DIABETES MELLITUS

机译:胰岛素的混合晶体,胰岛素衍生物,制备这些混合的晶体,包含这些混合的晶体的药物制剂的过程,因此将其用于治疗糖尿病

摘要

Mixed crystals composed of (a) unmodified insulin, des-Phe-B1 insulin, des-Thr-B30 (human) or des-Ala-B30 (pork, beef) insulin and (b) least one insulin having a basic modification at the C-terminal end of the B chain, preferably composed of human insulin and Arg-B31 human insulin and/or Arg2-(B31-32) human insulin. These mixed crystals are obtained by crystallization from aqueous solution within a narrow pH range (from about 5.5 to about 6.9). The mixed crystals show a specific moderately prolonged profile and are suitable for the treatment of diabetes mellitus.
机译:由(a)未修饰的胰岛素,des-Phe-B1胰岛素,des-Thr-B30(人)或des-Ala-B30(猪肉,牛肉)胰岛素和(b)在其上具有碱性修饰的至少一种胰岛素组成的混合晶体B链的C末端,优选由人胰岛素和Arg-B31人胰岛素和/或Arg2-(B31-32)人胰岛素组成。这些混合晶体通过在狭窄的pH范围(约5.5至约6.9)内从水溶液中结晶而获得。混合晶体显示出特定的适度延长的轮廓,并且适合于糖尿病的治疗。

著录项

  • 公开/公告号PH25587A

    专利类型

  • 公开/公告日1991-08-08

    原文格式PDF

  • 申请/专利权人 HOECHST AKTIENGESELLSCHAFT;

    申请/专利号PH19880036954

  • 发明设计人 MICHAEL DORSCHUG;RAINER OBERMEIER;

    申请日1988-05-20

  • 分类号A61K37/26;

  • 国家 PH

  • 入库时间 2022-08-22 05:57:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号